Capricorn Buys New Stake in Ionis Pharmaceuticals (IONS) With 163,000 Shares

On October 17, 2025, Capricorn Fund Managers Ltd disclosed a new stake in Ionis Pharmaceuticals, acquiring approximately 162,800 shares in a trade estimated at $10.65 million based on average quarterly pricing.According to a Securities and Exchange Commission (SEC) filing dated October 17, 2025, Capricorn Fund Managers Ltd reported a new position in Ionis Pharmaceuticals (NASDAQ:IONS). The fund added 162,800 shares during the quarter, with an estimated transaction value of $10.65 million. This stake brought Ionis Pharmaceuticals to 3.58% of the fund’s reportable AUM.This is a new position for Capricorn Fund Managers Ltd, representing 3.58% of 13F reportable AUM as of September 30, 2025.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool